Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2703PDF: 774HTML: 2320 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4534PDF: 1759HTML: 1170 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1821PDF: 1013HTML: 1834Tables: 191 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1446HTML: 629PDF: 864 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3620PDF: 1256HTML: 5089Incidence age-standardized rates for HL across the Mediterranean basin: 224 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2279PDF: 841HTML: 1695Figure 1: 212Table 1: 230 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1439PDF: 892HTML: 230 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2648PDF: 828HTML: 5361 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2245PDF: 1778HTML: 824 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3207PDF: 950HTML: 2582 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1481PDF: 747HTML: 4592Figure 1: Chest radiograph: 226Figure 2: Flow cytometer analysis of pleural fluid: 198 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1914PDF: 1027HTML: 219 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1901PDF: 428HTML: 226 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3664PDF: 2575HTML: 1560 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2535PDF: 810HTML: 1743 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3129PDF: 903HTML: 7293Kost Fig1: 206Kost Fig 2: 194Kost Fig3: 196Kost Fig 4: 209Kost Fig5: 209Kost fig 6: 194 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1868PDF: 588HTML: 357 -
OMENTAL SPLENOSIS MIMICKING PERITONEAL CARCINOMATOSIS
180PDF: 193HTML: 28 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1961PDF: 807HTML: 558 -
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
758PDF: 477HTML: 6277 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1075PDF: 951Suppl. Files: 607HTML: 97 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1173PDF: 526HTML: 381 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1588PDF: 579HTML: 864 -
-
Osteolytic bone lesions – A rare presentation of AML M6.
2039PDF: 1142HTML: 7982Untitled: 216 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3334PDF: 1736HTML: 1149
1 - 46 of 46 items







